{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:38:52Z","timestamp":1794350332150,"version":"4.9.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T00:00:00Z","timestamp":1551916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T00:00:00Z","timestamp":1551916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Due to limited availability of pharmacological therapies, triple-negative breast cancer (TNBC) is the subtype with worst outcome. We hypothesised that 2-Deoxy-D-Glucose (2-DG), a glucose analogue, may hold potential as a therapy for particularly aggressive TNBC. We investigated 2-DG\u2019s effects on TNBC cell line variants, Hs578T parental cells and their isogenic more aggressive Hs578Ts(i)<jats:sub>8<\/jats:sub> variant, using migration, invasion and <jats:italic>anoikis<\/jats:italic> assays. We assessed their bioenergetics by Seahorse. We evaluated metabolic alterations using a Seahorse XF Analyzer,\u00a0citrate synthase assay, immunoblotting and flow cytometry. We assessed the cancer stem cell (CSC) phenotype of the variants and 2-DG\u2019s effects on CSCs. 2-DG significantly inhibited migration and invasion of Hs578Ts(i)<jats:sub>8<\/jats:sub> versus Hs578T and significantly decreased their ability to resist <jats:italic>anoikis<\/jats:italic>. Investigating 2-DG\u2019s preferential inhibitory effect on the more aggressive cells, we found Hs578Ts(i)<jats:sub>8<\/jats:sub> also had significantly decreased oxidative phosphorylation and increased glycolysis compared to Hs578T. This is likely due to mitochondrial dysfunction in Hs578Ts(i)<jats:sub>8<\/jats:sub>, shown by their significantly decreased mitochondrial membrane potential. Furthermore, Hs578Ts(i)<jats:sub>8<\/jats:sub> had a significantly increased proportion of cells with CSC phenotype, which was significantly decreased by 2-DG. 2-DG may have benefit as a therapy for TNBC with a particularly aggressive phenotype, by targeting increased glycolysis. Studies of more cell lines and patients\u2019 specimens are warranted.<\/jats:p>","DOI":"10.1038\/s41598-019-39789-9","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T11:04:07Z","timestamp":1551956647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["2-Deoxy-D-Glucose inhibits aggressive triple-negative breast cancer cells by targeting glycolysis and the cancer stem cell phenotype"],"prefix":"10.1038","volume":"9","author":[{"given":"Sadhbh","family":"O\u2019Neill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"McNamee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa G.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9860-8262","authenticated-orcid":false,"given":"Lorraine","family":"O\u2019Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,7]]},"reference":[{"issue":"Suppl 6","key":"39789_CR1","doi-asserted-by":"publisher","first-page":"vi56","DOI":"10.1093\/annonc\/mds196","volume":"23","author":"J Crown","year":"2012","unstructured":"Crown, J., O\u2019Shaughnessy, J. & Gullo, G. Emerging targeted therapies in triple-negative breast cancer. Ann. Oncol. 23(Suppl 6), vi56\u201365 (2012).","journal-title":"Ann. Oncol."},{"key":"39789_CR2","doi-asserted-by":"publisher","first-page":"e532","DOI":"10.1038\/cddis.2013.60","volume":"4","author":"Y Zhao","year":"2013","unstructured":"Zhao, Y., Butler, E. B. & Tan, M. Targeting cellular metabolism to improve cancer therapeutics. Cell Death & Disease 4, e532, https:\/\/doi.org\/10.1038\/cddis.2013.60 (2013).","journal-title":"Cell Death & Disease"},{"key":"39789_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4161\/cam.26345","volume":"7","author":"T Han","year":"2013","unstructured":"Han, T. et al. How does cancer cell metabolism affect tumor migration and invasion? Cell Adhesion & Migration 7, 395\u2013403 (2013).","journal-title":"Cell Adhesion & Migration"},{"key":"39789_CR4","doi-asserted-by":"publisher","first-page":"8319","DOI":"10.1158\/0008-5472.CAN-06-0410","volume":"66","author":"JJ Christiansen","year":"2006","unstructured":"Christiansen, J. J. & Rajasekaran, A. K. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Research 66, 8319\u20138326 (2006).","journal-title":"Cancer Research"},{"key":"39789_CR5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrm1699","volume":"6","author":"BM Gumbiner","year":"2005","unstructured":"Gumbiner, B. M. Regulation of cadherin-mediated adhesion in morphogenesis. Nature Reviews. Mol. Cell Biol. 6, 622\u2013634 (2005).","journal-title":"Nature Reviews. Mol. Cell Biol."},{"key":"39789_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.canlet.2014.09.003","volume":"355","author":"D Zhang","year":"2014","unstructured":"Zhang, D. et al. 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy. Cancer Lett. 355, 176\u2013183 (2014).","journal-title":"Cancer Lett."},{"key":"39789_CR7","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/pros.21172","volume":"70","author":"M Stein","year":"2010","unstructured":"Stein, M. et al. Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies. The Prostate 70, 1388\u20131394 (2010).","journal-title":"The Prostate"},{"key":"39789_CR8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00280-012-2045-1","volume":"71","author":"LE Raez","year":"2013","unstructured":"Raez, L. E. et al. A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors. Cancer Chemo. Pharmacol. 71, 523\u2013530 (2013).","journal-title":"Cancer Chemo. Pharmacol."},{"key":"39789_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10585-008-9169-z","volume":"25","author":"L Hughes","year":"2008","unstructured":"Hughes, L., Malone, C., Chumsri, S., Burger, A. M. & McDonnell, S. Characterisation of breast cancer cell lines and establishment of a novel isogenic subclone to study migration, invasion and tumourigenicity. Clin. & Exp. Met. 25, 549\u2013557 (2008).","journal-title":"Clin. & Exp. Met."},{"key":"39789_CR10","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.ejca.2013.01.017","volume":"49","author":"K O\u2019Brien","year":"2013","unstructured":"O\u2019Brien, K. et al. Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells. Eur.J Cancer (Oxford, England: 1990) 49, 1845\u20131859 (2013).","journal-title":"Eur.J Cancer (Oxford, England: 1990)"},{"key":"39789_CR11","doi-asserted-by":"publisher","first-page":"32774","DOI":"10.18632\/oncotarget.5192","volume":"6","author":"K O\u2019Brien","year":"2015","unstructured":"O\u2019Brien, K. et al. miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity. Oncotarget 6, 32774\u201332789 (2015).","journal-title":"Oncotarget"},{"key":"39789_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1476-4598-13-71","volume":"13","author":"C Corcoran","year":"2014","unstructured":"Corcoran, C. et al. miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer. Mol. Cancer 13, 71\u201382 (2014).","journal-title":"Mol. Cancer"},{"issue":"5","key":"39789_CR13","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/bjc.2016.445","volume":"116","author":"S Breslin","year":"2017","unstructured":"Breslin, S., Lowry, M. C. & O\u2019Driscoll, L. Neratinib resistance and cross-resistance to other HER2-targeted drugs due to increased activity of metabolism enzyme cytochrome P4503A4. Br. J. Cancer 116(5), 620\u2013625 (2017).","journal-title":"Br. J. Cancer"},{"key":"39789_CR14","first-page":"1","volume":"17.04","author":"D Eigentler","year":"2015","unstructured":"Eigentler, D. & Wieth\u00fcchter, K. Lassing, Gnaiger Laboratory Protocol: Citrate synthase a mitochondrial marker enzyme. Mito. Physiol. Network 17.04, 1\u201311 (2015).","journal-title":"Mito. Physiol. Network"},{"issue":"11","key":"39789_CR15","doi-asserted-by":"publisher","first-page":"e113330","DOI":"10.1371\/journal.pone.0113330","volume":"9","author":"G Beutner","year":"2014","unstructured":"Beutner, G., Eliseev, R. A. & Porter, G. A. Jr. Initiation of electron transport chain activity in the embryonic heart coincides with the activation of mitochondrial complex 1 and the formation of supercomplexes. PLoS One 9(11), e113330, https:\/\/doi.org\/10.1371\/journal.pone.0113330 (2014).","journal-title":"PLoS One"},{"key":"39789_CR16","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1158\/0008-5472.CAN-13-2053","volume":"74","author":"S Rani","year":"2014","unstructured":"Rani, S. et al. Neuromedin U: a candidate biomarker and therapeutic target to predict and overcome resistance to HER-tyrosine kinase inhibitors. Cancer Research 74, 3821\u20133833 (2014).","journal-title":"Cancer Research"},{"key":"39789_CR17","first-page":"3117","volume":"22","author":"L O\u2019Driscoll","year":"2002","unstructured":"O\u2019Driscoll, L. et al. Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro. Anticancer Res. 22, 3117\u20133125 (2002).","journal-title":"Anticancer Res."},{"key":"39789_CR18","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.7150\/ijbs.13325","volume":"11","author":"W Zhang","year":"2015","unstructured":"Zhang, W., Zhang, S. L., Hu, X. & Tam, K. Y. Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target? Int. J. Biol. Sci. 11, 1390\u20131400 (2015).","journal-title":"Int. J. Biol. Sci."},{"key":"39789_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.14791\/btrt.2013.1.2.57","volume":"1","author":"MK Jha","year":"2013","unstructured":"Jha, M. K. & Suk, K. Pyruvate Dehydrogenase Kinase as a Potential Therapeutic Target for Malignant Gliomas. Brain Tumor Res. Treat. 1, 57\u201363 (2013).","journal-title":"Brain Tumor Res. Treat."},{"key":"39789_CR20","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/onc.2012.198","volume":"32","author":"G Sutendra","year":"2013","unstructured":"Sutendra, G. et al. Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer. Oncogene 32, 1638\u20131650 (2013).","journal-title":"Oncogene"},{"key":"39789_CR21","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1046\/j.1471-4159.2002.00945.x","volume":"82","author":"J Jacobson","year":"2002","unstructured":"Jacobson, J., Duchen, M. R. & Heales, S. J. Intracellular distribution of the fluorescent dye nonyl acridine orange responds to the mitochondrial membrane potential: implications for assays of cardiolipin and mitochondrial mass. J. Neurochem. 82, 224\u2013233 (2002).","journal-title":"J. Neurochem."},{"key":"39789_CR22","doi-asserted-by":"publisher","first-page":"e1336","DOI":"10.1038\/cddis.2014.285","volume":"5","author":"D Ciavardelli","year":"2014","unstructured":"Ciavardelli, D. et al. Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment. Cell Death & Dis. 5, e1336, https:\/\/doi.org\/10.1038\/cddis.2014.285 (2014).","journal-title":"Cell Death & Dis."},{"key":"39789_CR23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.yexmp.2010.08.006","volume":"89","author":"LM Ferreira","year":"2010","unstructured":"Ferreira, L. M. Cancer metabolism: the Warburg effect today. Exp. Mol. Pathol. 89, 372\u2013380 (2010).","journal-title":"Exp. Mol. Pathol."},{"key":"39789_CR24","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1038\/sj.onc.1202660","volume":"18","author":"AC Williams","year":"1999","unstructured":"Williams, A. C., Collard, T. J. & Paraskeva, C. An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: implications for clonal selection during colorectal carcinogenesis. Oncogene 18, 3199\u20133204 (1999).","journal-title":"Oncogene"},{"key":"39789_CR25","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1189\/jlb.69.4.522","volume":"69","author":"A Lardner","year":"2001","unstructured":"Lardner, A. The effects of extracellular pH on immune function. J. Leukoc. Biol. 69, 522\u2013530 (2001).","journal-title":"J. Leukoc. Biol."},{"key":"39789_CR26","first-page":"3847","volume":"63","author":"RA Gatenby","year":"2003","unstructured":"Gatenby, R. A. & Gawlinski, E. T. The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. Cancer Research 63, 3847\u20133854 (2003).","journal-title":"Cancer Research"},{"key":"39789_CR27","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.4161\/cc.24479","volume":"12","author":"JA Menendez","year":"2013","unstructured":"Menendez, J. A. et al. The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells. Cell Cycle 12, 1166\u20131179 (2013).","journal-title":"Cell Cycle"},{"key":"39789_CR28","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/stem.1904","volume":"33","author":"R Gargini","year":"2015","unstructured":"Gargini, R., Cerliani, J. P., Escoll, M., Anton, I. M. & Wandosell, F. Cancer stem cell-like phenotype and survival are coordinately regulated by Akt\/FoxO\/Bim pathway. Stem Cells 33, 646\u2013660 (2015).","journal-title":"Stem Cells"},{"key":"39789_CR29","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang, Y. et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537\u2013549 (2003).","journal-title":"Cancer Cell"},{"key":"39789_CR30","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature03799","volume":"436","author":"AJ Minn","year":"2005","unstructured":"Minn, A. J. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518\u2013524 (2005).","journal-title":"Nature"},{"key":"39789_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.stem.2011.08.010","volume":"9","author":"SM Dieter","year":"2011","unstructured":"Dieter, S. M. et al. Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell 9, 357\u2013365 (2011).","journal-title":"Cell Stem Cell"},{"key":"39789_CR32","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.freeradbiomed.2010.01.018","volume":"48","author":"T Hadzic","year":"2010","unstructured":"Hadzic, T. et al. Paclitaxel combined with inhibitors of glucose and hydroperoxide metabolism enhances breast cancer cell killing via H2O2-mediated oxidative stress. Free Radical Biol. & Med. 48, 1024\u20131033 (2010).","journal-title":"Free Radical Biol. & Med."},{"key":"39789_CR33","first-page":"739","volume":"5","author":"IM Ahmad","year":"2010","unstructured":"Ahmad, I. M., Mustafa, E. H., Mustafa, N. H., Tahtamouni, L. H. & Abdalla, M. Y. 2DG enhances the susceptibility of breast cancer cells to doxorubicin. Central Eur. J Biol. 5, 739\u2013748 (2010).","journal-title":"Central Eur. J Biol."},{"key":"39789_CR34","doi-asserted-by":"publisher","first-page":"017","DOI":"10.1038\/s41598-017-01801-5","volume":"7","author":"M Bizjak","year":"2017","unstructured":"Bizjak, M. et al. Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro. Scientific Reports 7, 017\u201301801 (2017).","journal-title":"Scientific Reports"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39789-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39789-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39789-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T07:18:32Z","timestamp":1671261512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39789-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,7]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["39789"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-39789-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,7]]},"assertion":[{"value":"10 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3788"}}